Kevin F. Staveley-O’Carroll, MD, PhD, MBA, FACSProfessor and Chair, Department of Surgery
|
|
Education
Post-Graduate Training
Awards
Degree | Institution | Major |
---|---|---|
BS | University of Notre Dame | Chemistry |
MD | University of Oklahoma College of Medicine | Medicine |
PhD | Johns Hopkins University School of Medicine | Pharmacology and Molecular Biology |
MBA | The Military College of South Carolina, The Citadel | Business Administration |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Postdoctoral | Johns Hopkins University School of Medicine | Oncology, Immunology, Pharmacology |
Residency | Johns Hopkins University School of Medicine | Surgery, (Chief 1998) |
Fellowship | Johns Hopkins University School of Medicine | Surgical Oncology |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Marion S. DeWeese, MD, Excellence in Arts and Science in the Operating Room | |
Moses Gunn Distinguished Professor | University of Michigan |
Visiting Professorship | Trinity College, Dublin, Ireland |
Visiting Professorship | The University of Auckland |
President | Association of Academic Surgeons |
Gardner Smith Memorial Lecture | Johns Hopkins Medical Institutions |
Guest Lecturer | Throckmorton Surgical Society |
Pfizer Visiting Professorship in Oncology | Albany Medical College |
Founding Director, Hepato-pancreatico-biliary Fellowship | Penn State University |
Mentored Clinical Scientist Award | |
Franklin Martin, MD, FACS, Memorial Faculty Research Award | American College of Surgeons |
Individual National Research Service Award | |
George D. Zuidema Research Award, (1993-1995) | |
Alpha Omega Alpha Honor Society | |
Monogram Award Winner - Division I NCAA, Varsity Wrestling, (1982-1984) |
Journal Articles
-
Nanoliposome C6-Ceramide in combination with anti-CTLA4 antibody improves anti-tumor immunity in hepatocellular cancer.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2022 Apr;36(4):e22250
-
Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response.
Journal for immunotherapy of cancer 2020 Oct;8(2):
-
Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Gastroenterology 2018 Mar;154(4):1024-1036.e9
-
Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.
Cancer letters 2017 Jul;39743-51
-
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model.
Journal of hepatology 2017 Jan;66(1):75-85
Reviews
-
Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy.
Cancers 2024 May;16(10):